168 related articles for article (PubMed ID: 2834257)
1. Role of opiate receptors in the regulation of colonic transit.
Kaufman PN; Krevsky B; Malmud LS; Maurer AH; Somers MB; Siegel JA; Fisher RS
Gastroenterology; 1988 Jun; 94(6):1351-6. PubMed ID: 2834257
[TBL] [Abstract][Full Text] [Related]
2. Effects of morphine and naloxone on feline colonic transit.
Krevsky B; Libster B; Maurer AH; Chase BJ; Fisher RS
Life Sci; 1989; 44(13):873-9. PubMed ID: 2927248
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective opioid agonists on feline colonic transit.
Krevsky B; Cowan A; Maurer AH; Butt W; Fisher RS
Life Sci; 1991; 48(16):1597-602. PubMed ID: 1850059
[TBL] [Abstract][Full Text] [Related]
4. Cisapride accelerates colonic transit in constipated patients with colonic inertia.
Krevsky B; Maurer AH; Malmud LS; Fisher RS
Am J Gastroenterol; 1989 Aug; 84(8):882-7. PubMed ID: 2667336
[TBL] [Abstract][Full Text] [Related]
5. The effect of naloxone-3-glucuronide on colonic transit time in healthy men after acute morphine administration: a placebo-controlled double-blinded crossover preclinical volunteer study.
Netzer P; Sendensky A; Wissmeyer MP; Baumeler S; Batista C; Scheurer U; Krause T; Reber P; Brenneisen R
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1334-41. PubMed ID: 18808445
[TBL] [Abstract][Full Text] [Related]
6. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
[TBL] [Abstract][Full Text] [Related]
7. Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial.
Foxx-Orenstein AE; Camilleri M; Szarka LA; McKinzie S; Burton D; Thomforde G; Baxter K; Zinsmeister AR
Neurogastroenterol Motil; 2007 Oct; 19(10):821-30. PubMed ID: 17539894
[TBL] [Abstract][Full Text] [Related]
8. Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice.
Matsumoto K; Umemoto H; Mori T; Akatsu R; Saito S; Tashima K; Shibasaki M; Kato S; Suzuki T; Horie S
Eur J Pharmacol; 2016 Jan; 771():220-8. PubMed ID: 26712376
[TBL] [Abstract][Full Text] [Related]
9. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
Porreca F; Burks TF
J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog.
Manara L; Bianchi G; Fiocchi R; Notarnicola A; Peracchia F; Tavani A
Life Sci; 1982 Sep 20-27; 31(12-13):1271-4. PubMed ID: 6183550
[TBL] [Abstract][Full Text] [Related]
11. Effect of alvimopan and codeine on gastrointestinal transit: a randomized controlled study.
Gonenne J; Camilleri M; Ferber I; Burton D; Baxter K; Keyashian K; Foss J; Wallin B; Du W; Zinsmeister AR
Clin Gastroenterol Hepatol; 2005 Aug; 3(8):784-91. PubMed ID: 16234007
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
Pillai NP; Bhargava HN
Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
[TBL] [Abstract][Full Text] [Related]
13. Stereospecific opiate receptors in the actions of thyrotropin releasing hormone and morphine on gastrointestinal transit.
Bhargava HN; Pillai NP
Life Sci; 1985 Jan; 36(1):83-8. PubMed ID: 2981381
[TBL] [Abstract][Full Text] [Related]
14. Effect of tolterodine on gastrointestinal transit and bowel habits in healthy subjects.
Bharucha AE; Seide B; Guan Z; Andrews CN; Zinsmeister AR
Neurogastroenterol Motil; 2008 Jun; 20(6):643-8. PubMed ID: 18312543
[TBL] [Abstract][Full Text] [Related]
15. Morphine tolerance and dependence in the rat intestine in vivo.
Williams CL; Bihm CC; Rosenfeld GC; Burks TF
J Pharmacol Exp Ther; 1997 Feb; 280(2):656-63. PubMed ID: 9023276
[TBL] [Abstract][Full Text] [Related]
16. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR
Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
[TBL] [Abstract][Full Text] [Related]
17. Colonic response to food in constipation.
Bouchoucha M; Devroede G; Faye A; Le Toumelin P; Arhan P; Arsac M
Int J Colorectal Dis; 2006 Dec; 21(8):826-33. PubMed ID: 15968522
[TBL] [Abstract][Full Text] [Related]
18. The effect of thyrotropin releasing hormone and morphine on gastrointestinal transit.
Pillai NP; Bhargava HN
Peptides; 1984; 5(6):1055-9. PubMed ID: 6099556
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.
Shin A; Acosta A; Camilleri M; Boldingh A; Burton D; Ryks M; Rhoten D; Zinsmeister AR
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):701-8.e1. PubMed ID: 25148765
[TBL] [Abstract][Full Text] [Related]
20. Effect of morphine and naloxone on intestinal transit in mice.
Wong CL; Roberts MB; Wai MK
Eur J Pharmacol; 1980 Jun; 64(4):289-95. PubMed ID: 7190096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
